Keywords: نتایج قلب و عروق; CI; confidence interval; COPD; chronic obstructive pulmonary disease; CV; cardiovascular; HF; heart failure; MI; myocardial infarction; NHS; National Health Service; NSAIDs; non-steroidal anti-inflammatory drugs; PDC; proportion of days covered; HR; hazar
مقالات ISI نتایج قلب و عروق (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نتایج قلب و عروق; cardiovascular outcomes; public reporting; quality;
Keywords: نتایج قلب و عروق; Diabetes; Hypertension; Cardiovascular outcomes; Diabetic kidney disease; Blood pressure goals;
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Cholesterol; High-density lipoprotein cholesterol; Low-density lipoprotein cholesterol; Triglycerides; Variability;
Keywords: نتایج قلب و عروق; cardiovascular and stroke endpoint definitions; cardiovascular and stroke outcome definitions; cardiovascular and stroke outcomes; cardiovascular endpoint definitions; cardiovascular endpoints; cardiovascular outcomes; clinical trial endpoint definitions;
Keywords: نتایج قلب و عروق; Oral appliances; Obstructive sleep apnea; Cardiovascular outcomes; Meta-analysis;
Keywords: نتایج قلب و عروق; Big endothelin-1; Stable coronary artery disease; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; Acute ischemic stroke; Glycemic variability; J-index; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; Malnutrition; Stable coronary artery disease; Obesity paradox; The controlling nutritional status score; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; Malnutrition; Stable coronary artery disease; Geriatric Nutritional Risk Index; Risk factors; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; SuPAR; PAD; CAD; Atherosclerosis; Cardiovascular outcomes; PAD-Related outcomes;
Keywords: نتایج قلب و عروق; Cardiovascular disease risk; Coronary stenting; Coronary angioplasty; Atherosclerosis; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Empagliflozin; Mechanisms; Sodium glucose cotransporter 2 inhibitors;
Keywords: نتایج قلب و عروق; Statins; Smoking; Cardiovascular outcomes; Systematic review; Meta-analysis;
Keywords: نتایج قلب و عروق; cardiovascular outcomes; type 2 diabetes; glucose lowering drugs; GLP agonists; SGLT-2 inhibitors;
Keywords: نتایج قلب و عروق; Cardiovascular risk; Clinical trials; Type 2 diabetes mellitus; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; Anticoagulant; Atrial fibrillation; Cardiovascular outcomes; Systemic embolism; Venous thromboembolism;
Keywords: نتایج قلب و عروق; AMPK; AMP-activated protein kinase; CHD; Coronary Heart Disease; CI; Confidence Interval; CV; Cardiovascular; DPP-IV inhibitors; Dipeptidyl peptidase-4 inhibitors; GLP-1 receptor agonists; Glucagon-like peptide-1 receptor agonists; HF; Heart Failure; HR;
Keywords: نتایج قلب و عروق; Visceral adipose tissue; Cardiovascular outcomes; Stable coronary artery disease; Elective percutaneous coronary intervention;
Keywords: نتایج قلب و عروق; SGLT2 Inhibitors; Dapagliflozin; Canagliflozin; Empagliflozin; CANVAS; CREDENCE; DECLARE-TIMI 58; Cardiovascular outcomes; Nonglycemic benefit of SGLT2 inhibitors;
Keywords: نتایج قلب و عروق; Statins; STEMI; Cardiovascular outcomes; STEMI; ST-elevation myocardial infarction; CAD; coronary artery disease; CVD; cardiovascular disease; LDL; low-density lipoprotein; hs CRP; sensitivity C-reactive protein; SMCs; smooth muscle cells; AMI; acute myoc
Keywords: نتایج قلب و عروق; cardiovascular outcomes; dipeptidyl peptidase-4; glucagon-like peptide-1 receptor agonist; BP; blood pressure; CI; confidence interval; CKD; chronic kidney disease; CV; cardiovascular; DPP-4; dipeptidyl-aminopeptidase-4; DPP-4i; dipeptidyl peptidaseâ
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Epidemiology; Mortality; Plasma renin activity;
Keywords: نتایج قلب و عروق; Arrhythmia; Cardiovascular outcomes; Chronic kidney failure; Hemodialysis
Keywords: نتایج قلب و عروق; all-cause mortality; cardiovascular outcomes; insulin; oral hypoglycemic agent; type 2 diabetes;
Keywords: نتایج قلب و عروق; Allopurinol; Cardiovascular outcomes; Gout; Hyperuricemia;
Keywords: نتایج قلب و عروق; Chronic heart failure; Microparticles; Predictive value; Cardiovascular outcomes
Keywords: نتایج قلب و عروق; Abdominal aortic calcification; Aortic calcification index; Chronic kidney disease; Cardiovascular outcomes
Keywords: نتایج قلب و عروق; Blood pressure; Cardiovascular mortality; Cardiovascular outcomes; Salt; Sodium;
Keywords: نتایج قلب و عروق; Resistant hypertension; Chronic kidney disease; Aldosterone; Diuretic; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; HMG-CoA reductase inhibitors; Statins; Chronic kidney disease; Cardiovascular outcomes; Renal outcomes; Kidney transplantation
Keywords: نتایج قلب و عروق; cardiovascular outcomes; left atrial function; left atrial volumeAF, atrial fibrillation; AMI, acute myocardial infarction; CCT, cardiac computed tomography; CHF, congestive heart failure; CMR, cardiac magnetic resonance; CVA, cerebrovascular accident; ε,
Keywords: نتایج قلب و عروق; Acute coronary syndrome; Worsening renal function; Cardiovascular outcomes;
Keywords: نتایج قلب و عروق; cardiovascular outcomes; mortality outcomes; renal outcomes; resistant hypertension;
Comparison of cardiovascular outcomes and all-cause mortality in patients with chronic hepatitis B and C: A 13-year nationwide population-based study in Asia
Keywords: نتایج قلب و عروق; Viral hepatitis; Atherosclerosis; Cardiovascular outcomes;
Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
Keywords: نتایج قلب و عروق; CKD; Cardiovascular outcomes; Osteoprotegerin; Osteopontin; TWEAK;
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Keywords: نتایج قلب و عروق; cardiovascular outcomes; coronary disease; platelet; CABG; coronary artery bypass graft; CI; confidence interval; CV; cardiovascular; DAPT; dual antiplatelet therapy; HR; hazard ratio; ICH; intracranial hemorrhage; KM; Kaplan-Meier; MACE; major adverse ca
Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes
Keywords: نتایج قلب و عروق; Chronic kidney disease; Diabetes; Subclinical atherosclerosis; Cardiovascular outcomes;
PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease
Keywords: نتایج قلب و عروق; PCSK9; Evolocumab; Alirocumab; Cardiovascular outcomes; Safety;
Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes?
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Diabetes; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter 2 inhibitors;
Impact of marital status on outcomes following ST-segment elevation myocardial infarction
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Marital status; Koreans;
Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial
Keywords: نتایج قلب و عروق; SGLT-2 inhibitors; Cardiovascular outcomes; Michigan model; Simulation;
Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials
Keywords: نتایج قلب و عروق; Diabetes Millitus; Meta-analysis; Glucagon-like peptide-1 receptors; Cardiovascular outcomes; CV; cardiovascular; CVOT; cardiovascular outcome trial; GLP-1 RA; GLP-1 receptor agonist; HbA1c; hemoglobin A1c; MI; myocardial infarction; CI; confidence interv
EMPA-REG OUTCOME: The Cardiologist's Point of View
Keywords: نتایج قلب و عروق; Cardiac workload; Cardiovascular outcomes; Empagliflozin; Myocardial oxygen consumption; Sodium glucose cotransporter 2 inhibitors;
EMPA-REG OUTCOME: The Endocrinologist's Point of View
Keywords: نتایج قلب و عروق; Cardiovascular outcomes; Empagliflozin; EMPA-REG OUTCOME; Major adverse cardiovascular events; Type 2 diabetes mellitus;
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data
Keywords: نتایج قلب و عروق; Diabetes; Drug labels; Cardiovascular outcomes;
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials
Keywords: نتایج قلب و عروق; Sodium-glucose cotransporter-2 inhibitors; Diabetes mellitus; Cardiovascular outcomes; Meta-analysis; Mortality;
Time to start implementing Lean and Six Sigma in the catheterization laboratory
Keywords: نتایج قلب و عروق; Lean; Six Sigma; Cardiovascular outcomes; Catheterization laboratory; Door-to-balloon time;
Parity, coronary heart disease and mortality in the old order Amish
Keywords: نتایج قلب و عروق; Mortality; Pregnancy; Cardiovascular outcomes; Coronary heart disease; Women;
Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis
Keywords: نتایج قلب و عروق; cardiovascular outcomes; cardiovascular risk factors; major adverse cardiovascular events psoriasis; tofacitinib; BID; twice daily; BP; blood pressure; CV; cardiovascular; HbA1c; glycated hemoglobin; HDL; high-density lipoprotein; hsCRP; high-sensitivity